Abiopharma

News list

Mates Sharon 🟢 acquired 49.0K shares (1 derivative) of Seaport Therapeutics, Inc. (SPTX) at $18.00 Transaction Date: Apr 30, 2026 | Filing ID: 204449

Full text

News bot May 4, 2026, 10:01 p.m.
🔍 Mates Sharon (Executive)

Company: Seaport Therapeutics, Inc. (SPTX)

Report Date: 2026-04-30
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 49,033
Detailed Transactions and Holdings:
- Acquired 49,033 shares of Stock Option (Right to Buy) at $18.0 per share (Derivative)
  Date: 2026-04-30 | Code: A | Expires: 2036-04-29 | equity_swap_involved: false | shares_owned_after: 49,033.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: 1/3rd of the shares underlying this option shall vest and become exercisable on April 30, 2027, with the remaining shares vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.